Call for Papers! Introducing the New BMC Cancer Collection: Advances in Preclinical Cancer Models
© Hyungkeun / stock.adobe.com
Cancer models are essential research tools, as they make it possible to elucidate the mechanisms involved in the appearance and progression of tumors, leading to the development of new therapeutic treatments. While widely used conventional two-dimensional cell models have been the gold standard for many decades, some of their major limitations include lack of representation of the stromal population, absence of a three-dimensional structure, and poor representation of the stromal population. ‘inter-. tumor and intra-tumor heterogeneity. Consequently, a multitude of new cancer models are emerging, which may advance the understanding of tumor pathophysiology and behavior. This will ultimately help improve clinical outcomes for patients, through the introduction of more personalized and targeted treatments into the clinical setting.
Recognizing the growing field of research, CMB Cancer welcomes submissions to a recently launched “Advances in pre-clinical cancer models” collection. Topics of interest for this special issue include, but are not limited to:
- Scaffold-based in vitro models
- 3D cell cultures
- Co-culture parameters
- Tumor organoids
- Large and small animal models
- Genetically modified cell lines and animal models
- Models of chemically induced tumors
- Xenotransplantation models (patient-derived xenografts, cell line-derived xenografts)
- Allograft models
This collection is now open for submissions!
This collection welcomes the submission of research articles. Journal articles will be considered at the discretion of the journal editor. If you would like to submit a review article, please email Chiara Cilibrasi first
Datasets and descriptions relevant to the collection will be considered in BMC Research Notes in the form of data notes. You can read more about this type of article here. This type of content will be published in BMC Research Notes and included in the final collection.
Before submitting your manuscript, make sure you have read our submission guidelines. Articles in this collection must be submitted through our submission system, Snapp. During the submission process you will be asked if you are submitting to a collection, please select ‘Advanced in Preclinical Cancer Models’ from the drop down menu. Please be sure to highlight in your cover letter that you are submitting to a collection.
Articles will undergo the journal’s standard peer review process and are subject to all standard journal policies. Articles will be added to the Collection as they are published.
If accepted for publication, article processing fees apply. Please click here to learn more about our standard waiver policy.
Submission deadline: April 30, 2023.
Check out the latest posts on the BMC Series blog homepage